—
C+
C+ The full Closelooknet — membership. Open the C+ overview

BeiGene, Ltd. (ONC) — Technical state

As of 2026-10-30 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 65 out of 100 (momentum 86 · quality 64 · valuation 31), as of 2026-11-01.
  • Signal: Uptrend stack intact — Trades +2% vs the 50-day and +14% vs the 200-day average, 4.7% below the 52-week high and +45.8% off the 52-week low; a golden cross printed 48 sessions ago. Computed from daily closes. (as of 2026-10-30)
  • Trend: BeiGene, Ltd. trades 2.0% above its 50-day and 14.0% above its 200-day moving average. (as of 2026-10-30)

BeiGene, now renamed BeOne Medicines AG, is an oncology company that discovers and develops cancer treatments across the United States, China and Europe. Its marketed products include a BTK inhibitor for blood cancers, a PD-1 antibody used in solid tumours and blood cancers, and separate treatments for Castleman disease and certain breast and solid-tumour cancers, alongside a wide clinical pipeline of compounds targeting different cancer pathways and partnerships with several other pharmaceutical firms.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ONC overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +2% vs the 50-day and +14% vs the 200-day average, 4.7% below the 52-week high and +45.8% off the 52-week low; a golden cross printed 48 sessions ago. Computed from daily closes.

The moving-average stack

Continue: the ONC chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-30

Quick answers

What is the current Closelooknet signal on ONC?

Uptrend stack intact — Trades +2% vs the 50-day and +14% vs the 200-day average, 4.7% below the 52-week high and +45.8% off the 52-week low; a golden cross printed 48 sessions ago. Computed from daily closes. As of 2026-10-30; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ONC above its 50-day and 200-day moving averages?

As of 2026-10-30, BeiGene, Ltd. trades +2% above its 50-day and +14% above its 200-day average, with the 20-day +0.9% away.

How far is ONC from its 52-week high?

4.7% below the 52-week high and 45.8% above the 52-week low, as of 2026-10-30.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.